Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia

  • Jae Yong Kwak
  • , Sung Hyun Kim
  • , Suk Joong Oh
  • , Dae Young Zang
  • , Hawk Kim
  • , Jeong A. Kim
  • , Young Rok Do
  • , Hyeoung Joon Kim
  • , Joon Seong Park
  • , Chul Won Choi
  • , Won Sik Lee
  • , Yeung Chul Mun
  • , Jee Hyun Kong
  • , Joo Seop Chung
  • , Ho Jin Shin
  • , Dae Young Kim
  • , Jinny Park
  • , Chul Won Jung
  • , Udomsak Bunworasate
  • , Narcisa Sonia Comia
    • Saengsuree Jootar, Arry Harryanto Reksodiputro, Priscilla B. Caguioa, Sung Eun Lee, Dong Wook Kim

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science